Literature DB >> 21488147

Protein kinase D in vascular biology and angiogenesis.

Ian M Evans1, Ian C Zachary.   

Abstract

The Protein Kinase D (PKD) family comprises diacylglycerol stimulated serine/threonine protein kinases that participate in many key signaling pathways in a diverse range of cells. Recent studies show that PKD isoforms 1 and 2 play critical roles in vascular biology and angiogenesis and there has been considerable progress in determining some of the key angiogenic signaling pathways mediated by PKD in endothelial cells. Less is currently known regarding the specific roles of PKD isoforms in endothelial cells and the role of PKD in smooth muscle cells. PKD is also emerging as a potentially important mediator of tumor growth and tumor angiogenesis and there is growing interest in PKD as a novel therapeutic target in cancer.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488147     DOI: 10.1002/iub.456

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  8 in total

1.  Specialized tip/stalk-like and phalanx-like endothelial cells from embryonic stem cells.

Authors:  Alicia A Blancas; Lian E Wong; Drew E Glaser; Kara E McCloskey
Journal:  Stem Cells Dev       Date:  2013-02-12       Impact factor: 3.272

2.  LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.

Authors:  Bin Ren; Brad Best; Devi Prasadh Ramakrishnan; Brian P Walcott; Peter Storz; Roy L Silverstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-24       Impact factor: 8.311

3.  Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer's Disease.

Authors:  Nicole El-Darzi; Natalia Mast; David A Buchner; Aicha Saadane; Brian Dailey; Georgios Trichonas; Irina A Pikuleva
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

4.  Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β.

Authors:  Ying Wang; Luke H Hoeppner; Ramcharan Singh Angom; Enfeng Wang; Shamit Dutta; Heike R Doeppler; Fei Wang; Tao Shen; Isobel A Scarisbrick; Sushovan Guha; Peter Storz; Resham Bhattacharya; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2019-09-06       Impact factor: 5.157

5.  MicroRNA expression profile and functional analysis reveal their roles in contact inhibition and its disruption switch of rat vascular smooth muscle cells.

Authors:  Ye-Ying Sun; Shan-Shan Qin; Yun-Hui Cheng; Chao-Yun Wang; Xiao-Jun Liu; Ying Liu; Xiu-Li Zhang; Wendy Zhang; Jia-Xin Zhan; Shuai Shao; Wei-Hua Bian; Bi-Hui Luo; Dong-Feng Lu; Jian Yang; Chun-Hua Wang; Chun-Xiang Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

6.  Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro.

Authors:  Attila Varga; Pál Gyulavári; Zoltán Greff; Krisztina Futosi; Tamás Németh; Laura Simon-Szabó; Krisztina Kerekes; Csaba Szántai-Kis; Diána Brauswetter; Márton Kokas; Gábor Borbély; Anna Erdei; Attila Mócsai; György Kéri; Tibor Vántus
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

7.  A time frame permissive for Protein Kinase D2 activity to direct angiogenesis in mouse embryonic stem cells.

Authors:  Martin Müller; Jana Schröer; Ninel Azoitei; Tim Eiseler; Wendy Bergmann; Ralf Köhntop; Qiong Lin; Ivan G Costa; Martin Zenke; Felicitas Genze; Clair Weidgang; Thomas Seufferlein; Stefan Liebau; Alexander Kleger
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

8.  Different regulation of physiological and tumor angiogenesis in zebrafish by protein kinase D1 (PKD1).

Authors:  Marcus Hollenbach; Sandra Jasmin Stoll; Kristina Jörgens; Thomas Seufferlein; Jens Kroll
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.